Is Pancolitis the Same as Ulcerative Colitis?
Title: Is Pancolitis the Same as Ulcerative Colitis?Category: Diseases and ConditionsCreated: 8/3/2021 12:00:00 AMLast Editorial Review: 8/3/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - August 3, 2021 Category: Nutrition Source Type: news

How Do You Get Diagnosed with Ulcerative Colitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - July 28, 2021 Category: General Medicine Source Type: news

VTE Risk Up for Children With Inflammatory Bowel Disease
Venous thromboembolism occurred less often for those with Crohn disease versus ulcerative colitis (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - July 27, 2021 Category: Cancer & Oncology Tags: Family Medicine, Gastroenterology, Internal Medicine, Oncology, Pediatrics, Pharmacy, Journal, Source Type: news

How Do You Diagnose Ulcerative Colitis?
Title: How Do You Diagnose Ulcerative Colitis?Category: Diseases and ConditionsCreated: 7/23/2021 12:00:00 AMLast Editorial Review: 7/23/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - July 23, 2021 Category: Nutrition Source Type: news

Cambridge microbiome startup's shares sliced in half after key trial failure
Microbiome startup Seres Therapeutics' shares are in a free fall after the company announced that its ulcerative colitis drug had failed in a mid-stage clinical trial. Seres (Nasdaq: MCRB) had been developing the drug in partnership with Nestlé Health Science as part of its suite of bacteria-based drugs, several of which are in clinical development. The ulcerative colitis study will be shut down, as the drug resulted in "no meaningful clinical differences" in a placebo comparison trial involving… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - July 22, 2021 Category: Health Management Authors: Rowan Walrath Source Type: news

STELARA ® (ustekinumab) Demonstrated Sustained Symptomatic and Corticosteroid-Free Remission Rates in Adults with Moderately to Severely Active Ulcerative Colitis at Nearly Three Years in Long-Term Extension of Phase 3 Trial
SPRING HOUSE, PENNSYLVANIA, July 9, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new three-year data from the long-term extension (LTE) of the STELARA® (ustekinumab) Phase 3 UNIFI study. The data demonstrated the majority (55.2 percent) of adult patients with moderately to severely active ulcerative colitis (UC) who initially responded to treatment with STELARA sustained symptomatic remissiona rates at nearly three years (week 152).1 Furthermore, a majority (96.4 percent) of the patients in symptomatic remissiona at week 152 were corticosteroid-free. These data are being pr...
Source: Johnson and Johnson - July 9, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

Adalimumab Safe and Effective in Children With Ulcerative Colitis Adalimumab Safe and Effective in Children With Ulcerative Colitis
Adalimumab is effective and well tolerated in children with moderate-to-severe ulcerative colitis, according to results of the ENVISION I study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 6, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Ustekinumab in Infliximab-refractory Pediatric UC Ustekinumab in Infliximab-refractory Pediatric UC
This study evaluated the efficacy of ustekinumab following failure of prior biologics in pediatric ulcerative colitis.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Crohn ’s Disease vs Ulcerative Colitis Difference
Crohn ’s Disease vs. Ulcerative Colitis: What's the Difference? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 21, 2021 Category: General Medicine Source Type: news

What Is Life Expectancy with Ulcerative Colitis
What Is the Life Expectancy with Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

What Is the Best Treatment for Ulcerative Colitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 18, 2021 Category: General Medicine Source Type: news

What Were First Symptoms of Ulcerative Colitis
What Were Your First Symptoms of Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 17, 2021 Category: General Medicine Source Type: news

What Is the Life Expectancy of Ulcerative Colitis
What Is the Life Expectancy of Someone with Ulcerative Colitis? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - June 17, 2021 Category: General Medicine Source Type: news

COVID Vaccines Appear Safe for People With IBD
THURSDAY, June 10, 2021 -- The Pfizer and Moderna COVID-19 vaccines appear to be safe for people with inflammatory bowel diseases (IBD), a new study finds. IBDs -- which includes Crohn's disease and ulcerative colitis -- are chronic conditions... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 10, 2021 Category: General Medicine Source Type: news

FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis FDA Approves Ozanimod (Zeposia) for Ulcerative Colitis
Once-daily, oral ozanimod is the first sphingosine-1-phosphate receptor modulator approved for adults with moderately to severely active ulcerative colitis.FDA Approvals (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - May 28, 2021 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news

'Good' bacteria show promise for clinical treatment of Crohn's disease, ulcerative colitis
(University of North Carolina Health Care) Balfour Sartor, MD, Midget Distinguished Professor of Medicine, Microbiology and Immunology, is the senior author of a study that shows how a novel consortium of bacteria that live in the digestive tracts of healthy individuals can be used to prevent and treat aggressive colitis in humanized mouse models. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 28, 2021 Category: International Medicine & Public Health Source Type: news

FDA Approves Bristol Myers Squibb ’s Zeposia (ozanimod), an Oral Treatment for Adults with Moderately to Severely Active Ulcerative Colitis
PRINCETON, N.J.--(BUSINESS WIRE) May 27, 2021 -- Bristol Myers Squibb (NYSE:BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Zeposia (ozanimod) 0.92 mg for the treatment of adults with moderately to severely active... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - May 27, 2021 Category: Drugs & Pharmacology Source Type: news

Janssen Presents Results of First Head-to-Head Study of Biologic Therapies in Patients with Moderate to Severe Crohn ’s Disease
SPRING HOUSE, PENNSYLVANIA, May 23, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced efficacy and safety data for STELARA® (ustekinumab) in Crohn’s disease (CD) and ulcerative colitis (UC),1-4including data from the SEAVUE study, the first head-to-head study of biologic therapies in patients with CD, presented in a Clinical Science Late-Breaking Abstract Plenary session.1 SEAVUE data showed treatment with STELARA demonstrated high rates of clinical remission, corticosteroid-free remission, clinical response and endoscopic response through one year in biologic-naïve p...
Source: Johnson and Johnson - May 24, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news

The 5 Goals of Colonoscopy in Ulcerative Colitis The 5 Goals of Colonoscopy in Ulcerative Colitis
Dr Stephen Hanauer remarks on ruling out mimics, establishing disease severity, surveilling for cancer, and other key reasons to perform routine colonoscopy.Medscape Gastroenterology (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 21, 2021 Category: Gastroenterology Tags: Gastroenterology Commentary Source Type: news

How Long Does an Ulcerative Colitis Flare-Up Last?
Title: How Long Does an Ulcerative Colitis Flare-Up Last?Category: Diseases and ConditionsCreated: 5/17/2021 12:00:00 AMLast Editorial Review: 5/17/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 17, 2021 Category: Nutrition Source Type: news

What Are the First Symptoms of Ulcerative Colitis?
Title: What Are the First Symptoms of Ulcerative Colitis?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 14, 2021 Category: Nutrition Source Type: news

What Is the Best Medicine for Ulcerative Colitis?
Title: What Is the Best Medicine for Ulcerative Colitis?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 14, 2021 Category: Nutrition Source Type: news

Is Ulcerative Colitis an Autoimmune Disease?
Title: Is Ulcerative Colitis an Autoimmune Disease?Category: Diseases and ConditionsCreated: 5/14/2021 12:00:00 AMLast Editorial Review: 5/14/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - May 14, 2021 Category: Nutrition Source Type: news

2001 to 2018 Saw Increase in Estimated Prevalence of IBD in Seniors
THURSDAY, May 13, 2021 -- During 2001 to 2018, the overall estimated prevalence of Crohn disease and ulcerative colitis increased among Medicare fee-for-service beneficiaries, with a higher increase seen among non-Hispanic Blacks, according to... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2021 Category: Pharmaceuticals Source Type: news

Low-Fat Diet Upped Quality of Life in Ulcerative Colitis Low-Fat Diet Upped Quality of Life in Ulcerative Colitis
Data suggest that even patients in remission could benefit from a healthier diet.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 11, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

New Oral Protein Promising for Ulcerative Colitis
New Oral Protein Shows Promise for Ulcerative Colitis (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - May 10, 2021 Category: General Medicine Source Type: news

New Oral Protein Shows Promise for Ulcerative Colitis New Oral Protein Shows Promise for Ulcerative Colitis
A recombinant anti-TNF alpha fusion protein showed safety and effectiveness in mild-to-moderate ulcerative colitis.Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - May 7, 2021 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

Life With an Ostomy Pouch for Ulcerative Colitis
Two people living with an ostomy pouch for ulcerative colitis (UC) share candid stories about their struggles and successes. (Source: WebMD Health)
Source: WebMD Health - April 23, 2021 Category: Consumer Health News Source Type: news

Is Almond Good for Ulcerative Colitis
? (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - April 20, 2021 Category: General Medicine Source Type: news

Relapse Prediction in Patients With UC in Clinical Remission Relapse Prediction in Patients With UC in Clinical Remission
What is the optimal colonoscopic strategy to determine the risk for clinical relapse in patients with ulcerative colitis in remission?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 19, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Defects in a specific cell type may cause ulcerative colitis
(University of Gothenburg) There are many variants of " goblet cells " in the intestines and they seem to have different functions, according to a new study from the University of Gothenburg. The study indicates that defects in goblet cells of a particular type may be a factor contributing to ulcerative colitis, an inflammatory bowel disease. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - April 19, 2021 Category: Biology Source Type: news

90-Day Specific Readmission for Clostridium difficile Infection After Hospitalization With an Inflammatory Bowel Disease Flare: Outcomes and Risk Factors, Inflammatory Bowel Diseases
Conclusions The 90-day CDI-specific readmission rate after the index admission of IBD flares was 0.1%. We found risk factors for CDI-associated readmissions such as history of Parkinson's disease, prior CDI, HIV-positive status, and alcohol abuse disorder. Finally, our study also revealed a high health care cost, charges, and burden. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 15, 2021 Category: Consumer Health News Source Type: news

An intercrypt subpopulation of goblet cells is essential for colonic mucus barrier function
In this study, however, we delineated their specific gene and protein expression profiles and identified several distinct goblet cell populations that form two differentiation trajectories. One distinct subtype, the intercrypt goblet cells (icGCs), located at the colonic luminal surface, produced mucus with properties that differed from the mucus secreted by crypt-residing goblet cells. Mice with defective icGCs had increased sensitivity to chemically induced colitis and manifested spontaneous colitis with age. Furthermore, alterations in mucus and reduced numbers of icGCs were observed in patients with both active and rem...
Source: ScienceNOW - April 15, 2021 Category: Science Authors: Nyström, E. E. L., Martinez-Abad, B., Arike, L., Birchenough, G. M. H., Nonnecke, E. B., Castillo, P. A., Svensson, F., Bevins, C. L., Hansson, G. C., Johansson, M. E. V. Tags: Cell Biology, Molecular Biology, Online Only r-articles Source Type: news

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatmentBasel, 13 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic ...
Source: Roche Media News - April 13, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Xolair (omalizumab) Prefilled Syringe for Self-Injection Across All Indications
●  Xolair for self-injection offers healthcare providers and appropriate patients another administration option for more flexibility in managing their treatmentBasel, 13 April 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has approved the company ’s supplemental Biologics License Application for Xolair® (omalizumab) prefilled syringe for self-injection across all approved U.S. indications.1 Xolair is the only FDA-approved biologic designed to target and block immunoglobulin E (IgE) for the treatment of moderate to severe persistent allergic ...
Source: Roche Investor Update - April 13, 2021 Category: Pharmaceuticals Source Type: news

What Are Indications for a Ileostomy?
Discussion There are three types of inflammatory bowel disease (IBD): Crohn’s disease (CD) – can affect entire gastrointestinal tract but often is discontinuous (i.e., has skipped areas), has transmural inflammation and disease, has granulomas Ulcerative colitis (UC) – affects the colon, is continuous (i.e., has no skipped areas) and has superficial mucosal ulcerations Unclassified IBD – has chronic colitis but not specific features of CD or UC The specific pathogenesis appears to be multifactorial with having a genetic predisposition (1.6 – 30% risk of developing UC if patient has first deg...
Source: PediatricEducation.org - March 29, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Inflammatory Burden Predicts Cancer Risk in Ulcerative Colitis Inflammatory Burden Predicts Cancer Risk in Ulcerative Colitis
The cumulative burden of histologic inflammation is a strong predictor of colorectal neoplasia risk in ulcerative colitis, according to a recent case-control study.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - March 25, 2021 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

A T-cell stimulatory protein and interleukin-10 synergize to prevent gut inflammation
(University of Alabama at Birmingham) Researchers have found an unexpected synergy between a T-cell stimulatory protein -- the ICOS ligand -- and interleukin-10, an immunoregulatory cytokine, to prevent inflammatory bowel disease in mice. The study will aid the understanding of, and future research into, this immune disorder, which includes Crohn's disease and ulcerative colitis. About 1.6 million Americans have inflammatory bowel disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 25, 2021 Category: International Medicine & Public Health Source Type: news

Common inflammatory bowel disease treatment linked to reduced COVID-19 antibody response
(University of Exeter) The findings arose from the CLARITY study, which recruited 6,935 patients with Crohn's disease and ulcerative colitis from 92 UK hospitals between September and December 2020. It found that fewer than half of people with IBD who were treated with infliximab had detectable antibodies after SARS-CoV-2 infection, the coronavirus that causes COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - March 22, 2021 Category: Infectious Diseases Source Type: news

New dawn in the war on a debilitating bowel disease
Father-of-two Garry Naftarski was one of the first British patients to try a new ulcerative colitis drug called filgotinib - and it transformed his life. (Source: the Mail online | Health)
Source: the Mail online | Health - March 20, 2021 Category: Consumer Health News Source Type: news

Mayo Clinic Q & amp;A podcast: The increasing prevalence of inflammatory bowel disease
Inflammatory bowel disease is common, and it is becoming more common in many populations. Dr. William Faubion Jr., a Mayo Clinic gastroenterologist, says inflammatory bowel disease is an umbrella term that covers Crohn's disease and ulcerative colitis, and that inflammatory bowel disease is an emerging public health problem. "The most recent estimates would be that, [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - March 16, 2021 Category: Databases & Libraries Source Type: news

Adalimumab Earns FDA Approval for Ulcerative Colitis in Children Adalimumab Earns FDA Approval for Ulcerative Colitis in Children
Adalimumab has received approval from the Food and Drug Administration for use in pediatric patients aged 5 years and older with moderately to severely active ulcerative colitis.FDA Approvals (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - March 3, 2021 Category: Gastroenterology Tags: Pediatrics News Alert Source Type: news

Immune-mediated Diseases and Risk of IBD Immune-mediated Diseases and Risk of IBD
Are individuals with other immune-mediated diseases at greater risk of developing ulcerative colitis or Crohn's disease?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 3, 2021 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Humira (adalimumab) Receives FDA Approval to Treat Pediatric Patients Living with Moderately to Severely Active Ulcerative Colitis
NORTH CHICAGO, Ill., Feb. 24, 2021 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) approved Humira (adalimumab) for the treatment of moderately to severely active ulcerative colitis in pediatric... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 24, 2021 Category: Drugs & Pharmacology Source Type: news

Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
Listen to FDA Drug Safety Podcast on Drug Safety Communication titled "Initial safety trial results find increased risk of serious heart-related problems and cancer with tofacitinib (Xeljanz, Xeljanz XR) (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 8, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Xeljanz, Xeljanz XR (tofacitinib): Drug Safety Communication -  Initial Safety Trial Results Find Increased Risk of Serious Heart-related Problems and Cancer with Arthritis and Ulcerative Colitis Medicine
The FDA is alerting the public that preliminary results from a safety clinical trial show an increased risk of serious heart-related problems and cancer with the arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib) compared to tumor necrosis factor (TNF) inhibitors. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 4, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

Initial safety trial results find increased risk of serious heart-related problems and cancer with arthritis and ulcerative colitis medicine Xeljanz, Xeljanz XR (tofacitinib)
Preliminary safety trial results show an increased risk of serious heart-related problems and cancer with Xeljanz, Xeljanz XR (tofacitinib). FDA will evaluate the results. Patients should not stop taking the medicine without first talking to their health care professionals. (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - February 4, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news

My Life With Ulcerative Colitis
An amateur athlete makes peace with his ulcerative colitis diagnosis and refuses to let his condition undermine his goals. (Source: WebMD Health)
Source: WebMD Health - February 3, 2021 Category: Consumer Health News Source Type: news

Surgery to heal inflamed gut may create new target for disease
(NYU Langone Health / NYU School of Medicine) A surgical procedure meant to counter ulcerative colitis, an immune disease affecting the colon, may trigger a second immune system attack, a new study shows. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - February 2, 2021 Category: Biology Source Type: news

Burden of ulcerative colitis substantial in Japan
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2021 Category: Drugs & Pharmacology Source Type: news